Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 71 Results

Title
Intervention Indication Therapeutic Area Year Actions
Betula verrucosa for tree pollen allergy-induced moderate to severe rhinoconjunctivitis Birch allergy vaccine (ALK tree AIT; Betula Verrucosa allergen extract) Tree pollen allergy Immunology 2021 View  |  Download
Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis Benralizumab (Fasenra; MEDI563) Eosinophilic granulomatosis with polyangiitis Cardiovascular System , Immunology 2022 View  |  Download
Benralizumab for treating hypereosinophilic syndrome Benralizumab (Fasenra; MEDI563) Hypereosinophilic syndrome (HES) Immunology 2023 View  |  Download
Benegrastim for treating chemotherapy-induced neutropenia in women with breast cancer Benegrastim Breast cancer Breast Cancer , Immunology , Toxicology 2022 View  |  Download
Belumosudil for graft versus host disease Belumosudil (SLx-2119; KD025; KD-025) Graft versus host disease (GvHD) Immunology 2021 View  |  Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE) Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Belimumab for lupus nephritis Belimumab (Benlysta; Lymphostat-B) Lupus nephritis Immunology , Nephrology 2019 View  |  Download
Belimumab (subcutaneous injection) add-on for systemic lupus erythematosus in children aged 5 to 17 years old Belimumab (Benlysta; Lymphostat-B) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2022 View  |  Download
BCX7353 for prevention of acute attacks of angioedema in hereditary angioedema BCX7353 (Berotralstat; ORLADEYO) Hereditary angioedema (HAE) Genetic Disorders , Immunology 2019 View  |  Download
Baricitinib for treatment of severe alopecia areata in adults Baricitinib (LY3009104; Olumiant) Alopecia areata Dermatology , Immunology 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications